Region Stockholm

The medical center is at the forefront of research in infectious diseases, with a particular focus on Staphylococcus aureus bacteraemia. This condition, caused by a common bacterium, can lead to severe infections if not treated effectively.

• Comparative treatment strategies
• Antibiotic resistance management
• Clinical outcome optimization

Through ongoing studies, the center is exploring the efficacy of different antibiotic regimens, such as bensylpenicillin versus cloxacillin, to improve patient outcomes and combat antibiotic resistance.

Specializing in cardiology, the center is dedicated to advancing the treatment of heart failure with preserved ejection fraction (HFpEF). This complex condition poses significant challenges due to its unique pathophysiology and limited treatment options.

• Heart failure management
• Pharmacological interventions
• Cardiovascular mortality reduction

Research efforts are focused on evaluating the impact of spironolactone and eplerenone in conjunction with standard care, aiming to reduce hospitalizations and cardiovascular deaths in HFpEF patients.